131 related articles for article (PubMed ID: 9811167)
1. Different contributions of the endothelin ET(A) receptor to hypertension induced by acute or chronic inhibition of nitric oxide synthesis.
Hashimoto N; Kuro T; Taira S; Matsumura Y
J Pharm Pharmacol; 1998 Sep; 50(9):1051-8. PubMed ID: 9811167
[TBL] [Abstract][Full Text] [Related]
2. Role of endothelin-1 in hypertension induced by long-term inhibition of nitric oxide synthase.
Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
Eur J Pharmacol; 1995 Jul; 280(3):311-6. PubMed ID: 8566099
[TBL] [Abstract][Full Text] [Related]
3. Effects of FR139317 on renal responses to acute nitric oxide blockade in anaesthetized rats.
Matsumura Y; Kuro T; Hashimoto N; Taira S
Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):441-4. PubMed ID: 9673820
[TBL] [Abstract][Full Text] [Related]
4. Ameliorating effect of an endothelin ETA receptor antagonist on renal function of DOCA-salt hypertensive rats.
Matsumura Y; Hashimoto N; Fujita K; Morimoto S
Eur J Pharmacol; 1997 Jan; 319(1):65-9. PubMed ID: 9030899
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of endothelin in anesthetized rabbits.
Ono N; Matsui T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Eur J Pharmacol; 1998 Oct; 359(2-3):177-84. PubMed ID: 9832389
[TBL] [Abstract][Full Text] [Related]
6. Renal vascular effects of the selective endothelin receptor antagonists in anaesthetized rats.
Matsuura T; Miura K; Ebara T; Yukimura T; Yamanaka S; Kim S; Iwao H
Br J Pharmacol; 1997 Sep; 122(1):81-6. PubMed ID: 9298531
[TBL] [Abstract][Full Text] [Related]
7. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y
Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
[TBL] [Abstract][Full Text] [Related]
8. ETA receptor-mediated role of endothelin in the kidney of DOCA-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Hashimoto N; Takaoka M; Morimoto S
Life Sci; 1996; 58(1):PL1-7. PubMed ID: 8628104
[TBL] [Abstract][Full Text] [Related]
9. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
10. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
[TBL] [Abstract][Full Text] [Related]
11. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction.
Banting JD; Friberg P; Adams MA
J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552
[TBL] [Abstract][Full Text] [Related]
12. Contribution of endogenous endothelin-1 to the maintenance of vascular tone: role of nitric oxide.
Gellai M; De Wolf R; Fletcher T; Nambi P
Pharmacology; 1997 Dec; 55(6):299-308. PubMed ID: 9413859
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular responses mediated by two types of endothelin ET(B) receptor in spontaneously hypertensive and Wistar-Kyoto rats.
Kuwahara M; Masuda T; Tsubone H; Sugano S; Karaki H
Eur J Pharmacol; 1996 Jan; 296(1):55-63. PubMed ID: 8720477
[TBL] [Abstract][Full Text] [Related]
14. Endothelin and gelatinases in renal changes following blockade of nitric oxide synthase in hypertensive rats.
Yang YL; Liu DD; Hsieh NK; Chen HI
Chin J Physiol; 2008 Jun; 51(3):186-95. PubMed ID: 18935914
[TBL] [Abstract][Full Text] [Related]
15. Role of endogenous endothelin and nitric oxide in tubuloglomerular feedback.
Kawabata M; Han WH; Ise T; Kobayashi K; Takabatake T
Kidney Int Suppl; 1996 Jun; 55():S135-7. PubMed ID: 8743535
[TBL] [Abstract][Full Text] [Related]
16. Do ETA receptors participate in the hemodynamic and renal effects of chronic nitric oxide blockade?
Fujihara CK; De Nucci G; Zatz R
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S462-5. PubMed ID: 8587446
[TBL] [Abstract][Full Text] [Related]
17. Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats.
Matsumura Y; Kita S; Okui T
Eur J Pharmacol; 2001 Mar; 415(1):45-9. PubMed ID: 11245851
[TBL] [Abstract][Full Text] [Related]
18. Effects of sarafotoxin S6c on renal haemodynamics and urine formation in anaesthetized dogs.
Matsuo G; Matsumura Y; Tadano K; Hashimoto T; Morimoto S
Clin Exp Pharmacol Physiol; 1997 Jul; 24(7):487-91. PubMed ID: 9248665
[TBL] [Abstract][Full Text] [Related]
19. Involvement of nitric oxide in endothelin ETB receptor-mediated inhibitory actions on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
Matsuo G; Matsumura Y; Tadano K; Hashimoto T; Morimoto S
J Cardiovasc Pharmacol; 1997 Sep; 30(3):325-31. PubMed ID: 9300316
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of endothelin-A and endothelin-B receptors on nociceptive information transmission in the spinal cord with FR139317, an endothelin-A receptor antagonist, and sarafotoxin S6c, an endothelin-B receptor agonist.
Yamamoto T; Shimoyama N; Asano H; Mizuguchi T
J Pharmacol Exp Ther; 1994 Oct; 271(1):156-63. PubMed ID: 7965709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
